LatchBio

The LatchBio platform lets bioinformatics teams store, transform, and analyze high-throughput data.

Design CRISPR guides. Understand Gene Editing Experiments. Analyze Genome-Scale Screening Data.

The page describes a scientific plotting framework with a reactive notebook interface and natural language prompts for interrogating biological data.

The company offers usage-based pricing that charges for the resources customers use.

The company builds a data infrastructure platform to enable the biotechnology scientific revolution.

LatchBio releases an updated version of its biology agent benchmarks on benchmarks.bio after observing misaligned behavior in frontier models. It maintains the evaluation suite continuously so biosecurity safeguards keep pace with agentic capabilities.

Sep 2026 · LatchBio BlogNews article

LatchBio proposes expanding its AI biosecurity benchmark suite to include microeukaryotic pathogens. The post argues that existing safeguards under-evaluate a broad class of eukaryotic organisms relevant to biosecurity risk.

Sep 2026 · LatchBio BlogNews article

LatchBio introduces a verifiable benchmark that evaluates AI agents on antisense oligonucleotide and siRNA design decisions for therapeutic discovery. It reports frontier agents’ performance across experimentally grounded tasks, providing a way to examine their capabilities in these two oligonucleotide modalities.

Sep 2026 · LatchBio BlogNews article

LatchBio acquires TwentyTwo, a YC S25 team building AI infrastructure for biosecurity, and forms Latch Biosecurity, led by TwentyTwo’s founders.

Jun 2026 · LatchBio BlogNews article